Format

Send to

Choose Destination
Ophthalmology. 2013 Sep;120(9):1756-60. doi: 10.1016/j.ophtha.2013.01.062. Epub 2013 Apr 28.

Rapid assessment of neurovisual integrity using multiple rarebits.

Author information

1
Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. lars.frisen@neuro.gu.se

Abstract

OBJECTIVE:

Rapid assessments of vision commonly rely on visual acuity testing alone. Although well suited for uncovering optical defects, visual acuity tests may fail to detect dysfunction of the neural substrate. There is a need for a rapid companion test sensitive to neural damage.

DESIGN:

Evaluation of diagnostic tests.

PARTICIPANTS AND CONTROLS:

Forty-seven patients with optic nerve or visual pathway lesions of low to moderate severities and 30 normal subjects.

METHODS:

A new computer-based quick test of neurovisual integrity was developed using segmented digits defined by rarebits, that is, receptive field-size bright dots briefly presented on a dark background.

MAIN OUTCOME MEASURES:

The test variable was the number of rarebits per segment; digit size was fixed. The test task was to call out verbally all digits that were seen during an 8-second presentation sequence. Test outcomes were contrasted with the results of an optotype acuity test and automated perimetry.

RESULTS:

All subjects easily grasped the test task. The normal subjects read, on average, 5.6 (± 0.5 standard deviation) of the 6 digits contained in the test sequence, whereas the patients averaged 3.3 ± 1.8 digits. The numbers of digits read correlated modestly with the acuity and perimetry results. Analysis of receiver operating characteristic curves indicated that the multiple rarebit test provided the best discrimination.

CONCLUSIONS:

The multiple rarebit test seemed to be highly capable of detecting neurovisual dysfunction. Its simplicity and uniquely short duration indicate a useful role in screening settings. The test is available free on the Internet.

FINANCIAL DISCLOSURE(S):

Proprietary or commercial disclosure may be found after the references.

PMID:
23631944
DOI:
10.1016/j.ophtha.2013.01.062
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center